Phyton Biotech® Launches New Video on its Specialty Fermentation Solutions
Watch the video now to learn more about Plant Cell Fermentation Technology®
Phyton Biotech Receives Patent for the Production of Ingenol-3-angelate, Using Plant Cell Fermentation (PCF®)
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Phyton Biotech Announces Appointment of New General Manager
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
Phyton Biotech Unifies International Operations Under New Leadership
DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, [...]
Phyton Biotech showcased plant cell fermentation at CPhI Worldwide
Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide [...]
Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin
Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection [...]
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO) Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech [...]
GenSpera Announces Partnership With Global Supplier
GenSpera Announces Partnership With Global Supplier Company to Partner with Phyton Biotech for Manufacture of the Key Ingredient in Mipsagargin SAN ANTONIO, Feb. 9, 2015 -- GenSpera, [...]
Phyton Biotech Receives CEP for Docetaxel API
Phyton Biotech Receives CEP for Docetaxel API VANCOUVER, Canada--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to [...]
Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation
Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation VANCOUVER, British Columbia--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted [...]
Phyton Biotech Receives “Research Group of the Year” Award
Phyton Biotech Receives "Research Group of the Year" Award SAN ANTONIO--Phyton Biotech announced that it has won the international “Research Group of the Year” 2011 Life Science [...]